{"id":1585,"date":"2024-02-19T19:46:01","date_gmt":"2024-02-19T19:46:01","guid":{"rendered":"https:\/\/gebro.es\/science-research\/asmacare-colaboracion-entre-humanitcare-y-gebro-para-el-desarrollo-de-una-solucion-digital-en-asma\/"},"modified":"2025-02-20T18:41:18","modified_gmt":"2025-02-20T18:41:18","slug":"asmacare-collaboracio-entre-humanitcare-i-gebro-per-al-desenvolupament-duna-solucio-digital-en-lasma","status":"publish","type":"project","link":"https:\/\/gebro.es\/ca\/ciencia-i-recerca\/asmacare-collaboracio-entre-humanitcare-i-gebro-per-al-desenvolupament-duna-solucio-digital-en-lasma\/","title":{"rendered":"Asmacare \u2013 Col\u00b7laboraci\u00f3 entre HumanITcare i Gebro per al desenvolupament d&#8217;una soluci\u00f3 digital en l&#8217;asma"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Resum:<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><br>Laboratoris Gebro Pharma, S.A. i HumanITcare van signar a principis de 2023 un conveni de col\u00b7laboraci\u00f3 per al desenvolupament i posterior comercialitzaci\u00f3 d&#8217;una plataforma per al seguiment remot dels pacients afectats d&#8217;asma. Els principals objectius d&#8217;aquesta monitoritzaci\u00f3 de l&#8217;asma de manera remota s\u00f3n els seg\u00fcents:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Per al pacient i el seu entorn:<\/strong>\u00a0<br><br>&#8211; Millorar el coneixement de la malaltia<br>&#8211; Incrementar l&#8217;adher\u00e8ncia al tractament<br><br><strong>Per al metge especialista:<\/strong><br><br>&#8211; Optimizar la c\u00e0rrega assistencial \u2013 prioritza les visites<br>&#8211; Optimizar el seguiment adequat dels pacients<br><br><strong>Per a la administraci\u00f3 p\u00fablica:<\/strong><br>&#8211; Reduir listes d&#8217;espera i visites no necess\u00e0ries<br><br><br>Aquest projecte s&#8217;inicia mitjan\u00e7ant la participaci\u00f3 en un ajut p\u00fablic promogut per ACCI\u00d3 (Generalitat de Catalunya)<br><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Entitas col\u00b7laboradores <\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">HumanITcare<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Duraci\u00f3n:<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Acord firmat al 2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resum: Laboratoris Gebro Pharma, S.A. i HumanITcare van signar a principis de 2023 un conveni de col\u00b7laboraci\u00f3 per al desenvolupament i posterior comercialitzaci\u00f3 d&#8217;una plataforma per al seguiment remot dels pacients afectats d&#8217;asma. Els principals objectius d&#8217;aquesta monitoritzaci\u00f3 de l&#8217;asma de manera remota s\u00f3n els seg\u00fcents: Per al pacient i el seu entorn:\u00a0 &#8211; Millorar [&hellip;]<\/p>\n","protected":false},"featured_media":1586,"parent":0,"menu_order":11,"template":"","class_list":["post-1585","project","type-project","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/project\/1585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/types\/project"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/media\/1586"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/ca\/wp-json\/wp\/v2\/media?parent=1585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}